Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

帕纳替尼既可作为异基因造血干细胞移植的有效过渡治疗，也可作为慢性粒细胞白血病伴髓系原始细胞危象患者的移植后维持治疗。